Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Long-Term Debt Repayments (2018 - 2020)

Neurogene's Long-Term Debt Repayments history spans 3 years, with the latest figure at $2000.0 for Q1 2020.

  • For Q1 2020, Long-Term Debt Repayments changed 0.0% year-over-year to $2000.0; the TTM value through Mar 2020 reached $9000.0, down 70.0%, while the annual FY2019 figure was $9000.0, 71.88% down from the prior year.
  • Long-Term Debt Repayments reached $2000.0 in Q1 2020 per NGNE's latest filing, roughly flat from $2000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $22000.0 in Q3 2018 to a low of $2000.0 in Q4 2018.
  • Average Long-Term Debt Repayments over 3 years is $4777.8, with a median of $2000.0 recorded in 2018.
  • The largest YoY upside for Long-Term Debt Repayments was 0.0% in 2019 against a maximum downside of 86.36% in 2019.
  • A 3-year view of Long-Term Debt Repayments shows it stood at $2000.0 in 2018, then changed by 0.0% to $2000.0 in 2019, then changed by 0.0% to $2000.0 in 2020.
  • Per Business Quant, the three most recent readings for NGNE's Long-Term Debt Repayments are $2000.0 (Q1 2020), $2000.0 (Q4 2019), and $3000.0 (Q3 2019).